Trial Profile
Pharmacokinetics of Pediatric Aluvia (Lopinavir /Ritonavir 100/25 mg) and Generic Lopinavir/Ritonavir Tablet Formulation (200/50 mg) in Clinically and Virologically Stable HIV-1 Infected Thai Adults.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 21 Jul 2020
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Nucleoside reverse transcriptase inhibitors
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 22 Jul 2010 New trial record